Search results
Results from the WOW.Com Content Network
Amgen, headquartered in California, is a publicly traded company and one of 30 in the Dow Jones Industrial, according to a state news release. It has more than 27,000 employees globally.
Encouraging comments from Amgen about the 52-week Phase 2 trial helped fuel an 8% rise in the company's shares over the past year. That rally lost steam in recent weeks as investors sought details ...
Amgen expects to have results from a 52-week, mid-stage trial of MariTide late this year. Some of those patients will be enrolled in another study for a second full year of dosing.
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
(Reuters) -Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, said on Tuesday its third-quarter product sales rose 5% as double-digit volume growth was offset by ...
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen is one of those companies developing brand-new obesity therapies. Even though this space is getting crowded, it could carve out a niche. Consider the biotech's leading weight loss candidate ...
(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...